Skip to main content

Profiles of Staphyloccocus aureus isolated from goat persistent mastitis before and after treatment with enrofloxacin

Abstract

Background

Staphylococcus aureus is one of the main causative agents of mastitis in small ruminants. Antimicrobial use is the major treatment, but there are many flaws linked to resistance, tolerance or persistence. This study aimed to verify changes in resistance, virulence and clonal profiles of S. aureus isolated from persistent mastitis goat milk before and after enrofloxacin treatment.

Results

MIC increased to at least one antimicrobial in S. aureus isolates after enrofloxacin treatment compared to before. The most detected resistance genes before and after treatment were tetK, tetM, and blaZ, with more resistance genes detected after enrofloxacin treatment (p < 0.05). Occasional variations in efflux system gene detection were observed before and after treatment. Nine virulence genes (hla, fnbA, fnbB, eta, etb, sea, sec, seh, and sej) were detected at both times, and between these, the hla and eta genes were detected more in isolates after treatment. All isolates of S. aureus belonged to the same sequence type (ST) 133, except for two S. aureus isolates prior to enrofloxacin treatment which were classified as ST5 and the other as a new one, ST4966. Isolates of S. aureus 4, 8, and 100 from before and after treatment had identical pulse types, while others obtained from other animals before and after treatment were classified into distinct pulse types.

Conclusion

There were occasional changes in the studied profiles of S. aureus isolated before and after treatment of animals with enrofloxacin, which may have contributed to the permanence of bacteria in the mammary gland, even when using traditional treatment, resulting in persistent mastitis.

Background

Goat farms suffer severe economic losses due to staphylococcal intramammary infections, with Staphylococcus aureus being the main cause of clinical mastitis in small ruminants [1]. Intramammary infections caused by S. aureus deserve special attention, due to the high prevalence and diverse forms of presentation of the disease. S. aureus is responsible for both acute clinical mastitis (gangrenous mastitis) and subclinical mastitis [2].

Mastitis is traditionally treated with the use of antimicrobials; however, the success of this therapy is low in many cases. The use of enrofloxacin in goats and other small ruminants in mastitis treatments has been widely accepted by the main routes of administration and has proved its efficacy in the resolution of mastitis [3, 4]. The phenomena of resistance, tolerance and persistence have brought greater complexity to the flaws of antimicrobial therapies [5]. S. aureus possesses different virulence factors that contribute to its persistence in mammary tissue [6]. Besides, the pattern of virulence genes can be used to determine the biovar and the relationship with the origin of the isolates [7]. In addition to virulence, a major concern in the control of mastitis is resistance to antimicrobials of the etiological agent. Finally, the characterization of the genetic diversity of S. aureus is important to understand the pattern of dispersion of the pathogen [6].

In this way, the present study aims to verify changes in the clonal, resistance and virulence profiles of S. aureus isolated from the milk of goats with persistent mastitis, before and after treatment with enrofloxacin.

Results

Resistance profile

The minimum inhibitory concentration (MIC) values are shown in Table 1. Considering the same animal, a MIC increase to at least one antimicrobial was observed for all S. aureus isolates after treatment, compared with the values found before it. This was observed in a greater number of isolates for enrofloxacin, ciprofloxacin, and oxacillin MIC values, followed by penicillin, gentamicin, and ampicillin, then by vancomycin and lastly by tetracycline MICs (Table 1, in bold).

Table 1 Values of Minimum Inhibitory Concentration of different antimicrobials in Staphylococcus aureus isolates using the E-test®

According to the cutoff points of the Clinical and Laboratory Standards Institute [8] and Macgowan and Wise [9], all isolates showed resistance profiles for tetracycline, penicillin, ampicillin and oxacycline, while for the other antimicrobials there were variations (Table 1). In addition, after treatment some S. aureus isolates changed the profile for antimicrobial resistant to vancomycin and ciprofloxacin, as highlighted in Table 1.

Table 2 Virulence and resistance genes detected in Staphylococcus aureus isolates from mastitis goat milk

The most frequently detected resistance genes in S aureus isolates before and after treatment were tetK, tetM and blaZ (Table 2). More resistance genes were detected in the isolates obtained after treatment with enrofloxacin (60.87%, 28/46) compared to those detected in S. aureus isolated prior to treatment (39.13%, 18/46) (P < 0.05). The genes aac(6‘)/aph(2’), aph(3′)-llla and ermC were not detected at both moments.

S. aureus from animals 7 and 9 showed greater variation in the amount of resistance genes detected before and after treatment (Table 2).

Regarding multidrug efflux systems genes, norC and tet38 were the most prevalent, being found in 17 of 18 isolates (94.4%) (Table 2). S. aureus from animal 9 varied the most: there was no gene before treatment and after treatment it was positive for three genes. Moreover, in isolates from animals 5 and 7, after treatment the lmrS gene was detected in addition to the genes that were detected also before treatment. The norB, mgrA and msrA genes were not detected in S. aureus isolated at the two studied moments.

Virulence profile

The detection of S. aureus virulence genes isolated from goat milk with clinical mastitis before and after treatment with enrofloxacin are shown in Table 2. Of the 16 genes tested, only nine genes (hla, fnbA, fnbB, eta, etb, sea, sec, seh and sej) were detected in S. aureus isolated before and after enrofloxacin treatment. Among these, the genes hla (alpha-hemolysin) and eta (exfoliative toxin A) were more detected in S. aureus isolated after treatment. However, there were no statistical difference. The others, related to adhesion and toxins, remained constant at both times.

Clonal profile

S. aureus isolates from the animals 4, 8 and 100, before and after treatment, presented identical pulse types, whereas others obtained from other animals, before and after treatment, were classified into distinct or even unclassified pulse types using 95% similarity and 5% tolerance and optimization, as shown in Fig. 1.

Fig. 1
figure1

Dendrogram of Pulsed Field Gel Electrophoresis of 18 Staphylococcus aureus isolates and your Sequence Types. Dendogram generated by the UPGMA/Dice (Bionumerics, Applied Maths). S. aureus isolates from the animals 4, 8 and 100, before and after treatment, presented identical pulse types (95% similarity and 5% tolerance and optimization). Sixteen isolates were within the same ST 133, the exceptions were S. aureus 5 and 101 from before treatment, which presented in ST 5 and a new ST 4966, respectively. c: isolates of goats with mastitis before treatment; p: isolates of goats with mastitis after treatment. Red dotted line: clusters (I-III); * Isolated not clustered in clusters

From the MLST, all S. aureus isolates belonged to the same ST 133, except S. aureus 5 and 101 isolated before treatment with enrofloxacin. Isolate 5c belonged to ST 5 and S. aureus 101c was classified as a novel ST 4966 (Fig. 1).

Discussion

In goats mastitis, the most important bacterial genus is Staphylococcus [10, 11] and the severity of the infections caused by S. aureus in different types of mastitis is associated with its virulence factors which allow it to adhere to surface, invade or avoid the immune system, and cause harmful toxic effects to the host [12, 13].

In general, considering the same animal as origin, the MICs of the tested antimicrobials increased for the isolates obtained after treatment and in some cases changed the profile for resistance (Table 1). There was an increase in the MIC for enrofloxacin in five isolates obtained after treatment, whereas in four isolates, the MIC was maintained (Table 2). The mechanism of action of fluoroquinolones is to inhibit DNA gyrase and thus inhibit bacterial cell division. For beta-lactams and fluoroquinolones, the inhibition of replication plays a central role in the development of the persistence phenomenon [5]. Persisters are not as dormant as spores but are slow or very slow growers [14]. In addition, gene exchange events can be increased up to 100-fold in persistent S. aureus isolates [15].

Of the 10 resistance genes tested, seven were detected in S. aureus isolated before and after treatment, but with a greater detection in isolates after treatment (p < 0.05). The tetM and tetK genes are associated with tetracycline resistance. The gene tetM is located in conjugative transposons, whereas the tetK gene is located in a plasmid, which is the transfer of genes to other species of bacteria [16, 17]. The blaZ gene encoding penicillin resistance may be located both chromosomally and in plasmids [17].

In the present study, the mecA gene was detected before and after treatment. Expression of this gene confers resistance to methicillin and most beta-lactams. The gene mecA is located on a mobile genetic element ‘staphylococcal cassette chromosome mec (SCCmec) [18]. Methicillin-resistant S. aureus (MRSA) is an important human and animal pathogen that is linked to several infections. Recently, the isolation of MRSA from dairy cows with mastitis [19,20,21], raw milk and dairy products has been reported worldwide [22, 23], as well as in goats with mastitis [24, 25].

The ermA and ermB genes were found in our study, these genes are linked to resistance to macrolides, lincosamide, and streptogramin once they belong to erythromycin ribosome methylase family of genes (ermA, ermB, and ermC). These genes are widely distributed in isolates of Staphylococcus spp. from humans and animals and are located mainly in plasmids [26]. The presence of these genes is concerning due to the possibility of the transfer of these genes to other bacteria, or even the contamination to other animals, including humans with multiresistant bacteria.

The ant(4′)-Ia gene codes for aminoglycoside modifying enzymes (AME), conferring resistance to aminoglycosides. It was found in isolates before and after treatment, but in isolates from animals 5 and 7, it appeared only after treatment.

The major facilitator superfamily (MFS) is one of the oldest and most diverse efflux system family in S. aureus, with more than 1000 members. Since its discovery, MFS transporters have become the target of studies because of the ability to confer resistance to multiple drugs [27]. The presence of MFS is clinically relevant, mainly in Gram-positive bacteria, where the most important genes for S. aureus norA, norB, norC and lmrS are located in genome [28]. The norA and norC genes confer resistance to fluorquinolones, whereas the lmrS gene confers resistance to linezolid, phenicol (chloramphenicol, florfenicol), trimethoprim, erythromycin, kanamycin and fusidic acid [28]. The norA, norC and lmrS genes were similarly detected in S. aureus isolated from mastitis before and after treatment, and may be an important factor related to treatment failures and the persistence of caprine mastitis. In this study, the treatment was performed with enrofloxacin, antimicrobial for which the etiological agent was sensitive, and that has good distribution in the udder. On the other hand, enrofloxacin was known to be widely used on the property studied for the treatment of pneumonia in young goats.

The mgrA gene acts as a global regulator, regulating some virulence factors such as capsule synthesis and the gene expression of multidrug efflux systems [28]. This gene acts as a negative regulator for the tet38, norB and norC genes contributing to quinolone resistance [29]. In this study, the regulatory gene mgrA was not detected, suggesting that the efflux systems tet38 and norC were active. The Tet38 efflux system is encoded by chromosomes and confers resistance to tetracycline. In addition, the presence of this system is related to increased S. aureus invasion in epithelial cells, indicating that it may play new roles, in addition to resistance to antimicrobial drugs [30].

Of the 16 virulence genes tested, nine were detected (Table 2). Alpha hemolysis (hla, hlb and hlγ) permeabilizes cell membranes, destroys macrophages and lymphocytes and alters platelet morphology. ETA and ETB exfoliative toxins hydrolyze desmoglein 1, a cadherin responsible for the integrity of the adhesive structures, resulting in skin exfoliation, and lead to the destruction of the epidermal barrier facilitating the efficient progression of infection [31].

Mørk and colleagues [32] observed the presence of S. aureus toxin genes obtained from healthy goats (71%) and goats with mastitis (86%), showing that the presence of enterotoxin-encoding genes is common in S. aureus. On the other hand, the SEC toxin affects the bovine immune response, resulting in immunosuppression, which promotes the persistence of S. aureus in the bovine mammary gland and contributions to chronic intramammary infection [33]. The sec gene was found in this study in three isolates before and after treatment, suggesting that this may play an important role in the virulence and persistence of this pathogen in the mammary gland of goats.

S. aureus 4c/4p, 8c/8p, and 100c/100p obtained from the respective animals 4, 8, and 100, before and after enrofloxacin treatment, were present in pulse types, I, I, and III, respectively, and were within the same ST 133 (Fig. 1). which was previously associated with the persistence of subclinical bovine mastitis in Brazilian herds [34]. Differences in pulsotypes can alter the form of manifestation of the disease, since a given pulsotype can confer greater or lesser severity of symptoms and also be more or less associated with persistence [35]. In our study, the three pulsotypes found may be associated with persistence, but for some animals, the pulsotypes of isolates obtained from the same animal before and after treatment were different. In addition, the same resistance genes and multidrug efflux systems were found, as well as small point variations in MIC values among S. aureus isolated from the same animal before and after treatment (Tables 1 and 2). Regarding the presence of virulence genes, it was verified that S. aureus 8c and 8p have the same genes and in S. aureus 8 and 100 there was only one gene addition in S. aureus isolated after treatment (Table 2); thus, indicating that they may be the same isolate, which could not be eliminated in treatment and consequently resulted in persistent mastitis.

Previous studies in other geographic distributions of isolates have associated ST or Clonal Complex (CC) 133 with small ruminants [36,37,38,39]. S. aureus isolated from animals is commonly designated for host-specific ST, such as ST 133 from sheep, goats and cattle distributed in different countries [40,41,42,43]. We characterized 18 isolates of S. aureus, 16 S. aureus as ST 133, one as ST 5 and one new, ST 4966, not previously described. CC 5 or ST 5 is a common clonal complex of S. aureus [44] isolated from bovine mastitis [45], including in Brazil [46], buffalo milk [47], humans and milk and dairy products samples [23, 48].

Aires-de-Souza [49] proposed that CC 133 isolates may have evolved and adapted to small ruminants, originating from humans due to adaptive diversification of the genome resulting from allelic variation, a loss of genes or the horizontal acquisition of mobile genetic elements. In the case of isolate 5c there was a modification in the allele corresponding to the yqil gene related to the metabolism of Acetylcoenzyme A acetyltransferase (Fig. 1). Isolate 101 was modified from all alleles, so it was not possible to classify it, thus resulting in a new ST. Although the other isolates (six before and six after treatment) had different pulsetypes, their resistance and virulence profiles were generally not significantly altered.

MLST provides an excellent tool for investigating the population structure of S. aureus globally [50]. Indeed, MLST provide data that can be compared on a global scale and allow typing of important S. aureus clones such as ST 5 and ST 133 involved in human and animal infections, that are non-typable by the standard PFGE method (using smaI) due to DNA methylation [51, 52]. Besides, some authors claim that the discriminatory ability of MLST is low when compared with other techniques such as PFGE [53].

The use of antimicrobials, even for therapeutic purposes, may induce the emergence of mutations, which may be related to the persistence phenomenon, by altering some of the profiles of etiological agents. Bacterial persistence is a phenomenon that involves the emergence of subpopulations of clonal groups that enter a dormant state and return to multiplication after drug withdrawal [54]. This may have occurred in the present study, where differences in resistance, virulence and clonal profiles were observed in S. aureus isolated from the same animals before and after treatment, even after a short treatment period (7 days). Cirz et al. [55] verified that, in the presence of ciprofloxacin, a fluoroquinolone, after 120 min of exposure, a rapid diversification of the S. aureus population occurs, inducing the mobilization of the prophage, as well as significant alterations to the metabolism, in addition to inducing the SOS response, leading to adaptive mutagenesis. Schelli et al. [56] found metabolic changes in response to stress in S. aureus isolates incubated with quinolones for a short time (after 6 h).

Of the seven major genes of S. aureus multidrug efflux systems, five were detected in the present study in S. aureus isolates before and after treatment. Thus, the hypothesis of the persistence of isolates, which are associated with a replication arrest, biofilm production, activation of efflux pumps and stimulation of mutation events and horizontal gene transfer (HGT) [5], is reinforced.

Whereas microbial persistence describes a phenomenon in which microorganisms are considered susceptible to drugs when tested outside the host but are able to survive within the body despite the use of the appropriate antimicrobial [57], once again the persistence theory of microorganism resulting in disease persistence is emphasized.

Conclusion

This study demonstrated that S. aureus with certain clonal characteristics, resistance profiles and virulence possess abilities that may contribute to its persistence in mastitis, leading to severe infections and subsequent chronicity. In addition, it can be concluded that even using conventional mastitis treatment, with isolation and selection of antibiotic-sensitive in antibiogram, respecting the appropriate doses and application intervals, occasionally some profiles of the etiologic agent may be changed, contributing to the development of persistent mastitis.

Methods

This project was approved by the Committee of Ethics in the Use of Animals of the Universidade Federal de Viçosa, CEUA / UFV, with study number 42/2014.

Animals and Staphylococcus aureus isolates

Nine animals, four Saanen and five Alpine breed (specialized breeds for milk production), aged 2–4 years, with a body weight of approximately 50 kg, identified by numbers 4, 5, 6, 7, 8, 9, 10, 100, and 101 were selected. These goats, belonging to the goat farming sector, Animal Science Department, of the Universidade Federal de Viçosa. This sector is located in Viçosa, Minas Gerais, 20°46′22.8″S 42°51′10.8″W, with a Cwa climate according to Köppen climate classification. The animals are kept under intensive farming in a free stall regime, with a high-level mechanical milking system and automatic cleaning of milk pipes.

The animals selected were examined and diagnosed with clinical mastitis caused by S. aureus. After antibiogram results, these animals were treated with enrofloxacin (Kinetomax® – Bayer), with a dose of 5 mg/kg every 24 h, administered intramuscularly for seven consecutive days. Twenty-one days after the completion of treatment, these animals continued to have clinical mastitis. New milk samples were collected and S. aureus was isolated again. Thus, 18 isolates of S. aureus were obtained (nine before treatment and nine after treatment). All the isolates were identified by phenotypic (morphostaining and biochemical) and genotypic (femA gene detection by PCR and sequencing) methods [58], and stored at −80 °C in microtubes containing Heart Brain Infusion (BHI) broth with 20% glycerol.

After the experiment, the animals remained in their place of origin and returned to receive the treatment recommended by the technicians responsible for the sanitary management of the place.

S. aureus isolates were identified according to the animal number to which they were isolated and the letters C and P subscribed to the numbers means before and after treatment with enrofloxacin, respectively.

Resistance profile

Minimum inhibitory concentration (MIC)

The minimum inhibitory concentrations (MICs) were assessed using the E-test® method (bioMerieux). The bacterial inoculum was prepared in Müeller-Hilton (MH) broth and the turbidity was adjusted to McFarland scale 0.5 (~ 1.5 × 108 CFU/mL). The inoculum was spread on a plate containing MH agar, and the E-test strips were dispensed on the surface of the agar. The plates were then incubated at 37 °C for 24 h. After the incubation period, the plates were read and interpreted following the manufacturer’s guidelines and published cut-off points [8, 9]. S. aureus ATCC® 29213 was used as control. Were tested penicillin, oxacillin, ampicillin, gentamicin, tetracycline, ciprofloxacin, vancomycin and enrofloxacin, antimicrobial agents of importance in the treatment of mastitis. The mean of three replicates was used.

Virulence and resistance genes detection

DNA extraction was performed using the Wizard® Genomic DNA Purification Kit (Promega®), following the protocol described for Gram-positive bacteria, modified by the addition of 100 μL lysostaphin (100 μg/mL, Sigma®) and incubation at 37 °C, in a water bath for 45 min at the lysis stage.

PCR was used for detection of resistance, multidrug efflux system and virulence genes (Table 3). The PCRs was performed using 12.5 μL of Green Master Mix 2X (Promega Corp.), 10 μM of each primer (forward and reverse), 2 μL (~ 100 ng/μL) of DNA and nuclease-free water for the final volume of 25 μL for reaction. The virulence genes seg + sei and seh + sej were detected using multiplex PCR [65].

Table 3 Primers used in the detection of Staphylococcus aureus resistance, multidrug efflux system and virulence genes

The reference strains of S. aureus FRI 100 (sea); ATCC 14458 (seb); ATCC 19095 (sec, sec, seh and sei), FRI 472 (sed) and FRI 326 (see) were used as positive controls and were provided by Fundação Osvaldo Cruz (Fiocruz-RJ, Brazil).

Clonal profile

Pulsed field gel electrophoresis (PFGE)

Macro-restriction analyses of S. aureus DNA were performed following the protocol described by Spanamberg et al. [66], with some modifications. For the preparation of the plugs of the 18 isolates of S. aureus (nine before and nine after treatment), the isolates were inoculated in tryptone soy broth (TSB) and incubated at 37 °C for 16 h, until obtaining an optical density (OD) of 1 (ʎ = 590 nm). After an adjustment for OD, 150 μL of the bacterial suspension was transferred to micro tubes and centrifuged at 16,000×g for 5 min. The supernatant was discarded and the pellet was resuspended in 150 μL Cell Suspension Buffer + 7 μL lysostaphin (1 mg/mL) + 7 μL lysozyme (10 mg/mL) + 150 μL low melting agarose 1% and maintained at 50 °C. For enzymatic digestion, about 1/5 of the original plug was sectioned and added to properly identified 0.5 mL micro tubes. The plugs were subjected to an initial stabilization in 200 μL of 1X enzyme buffer (TE) for 10 min. After the removal of the buffer, 150 μL of 1X TE was added again, accompanied by 20 U restriction enzyme SmaI (Promega Corporation, Madison, USA), followed by incubation at 25 °C for 4 h.

The DNA present in the plugs was separated using a CHEF-DRIII apparatus (Bio-RadLaboratories, Hercules, CA, USA), according to the following run protocol: 40–100 s for 2 h, followed by 2–35 s for 20 h at an angle of 120°, 6 V/cm, in 0.5X TBE buffer maintained at 14 °C. Pulse Marker™ 50–1.000 kb (Sigma – Aldrich Co.) was used as a marker. The obtained gels were developed in an immersion bath with UniSafeDye® intercalating dye (Uniscience, Brazil), visualized in a transilluminator under ultraviolet light and photographed for further analysis. The obtained bands were analysed using BioNumerics v.6.6.4 software (AppliedMaths, Kortrijk, Belgium). For the analysis and interpretation of the results, a dendrogram was constructed using the unweighted pair group method with arithmetic mean (UPGMA) method, with a similarity coefficient of 95%, and a tolerance and optimization of 5% each [67].

Multi locus sequence typing (MLST)

Seven housekeeping genes were used: arcC (Carbamate kinase), aroE (shikimate dehydrogenase), glpF (glycerol kinase), gmk (guanylate kinase), pta (phosphate acetyltransferase), tpi (Triose phosphate isomerase) and yqiL (Acetyl coenzyme A) acetyl transferase) [68].

The MLST analysis was performed through PCR reactions, with each reaction containing 25 μL of Green Master Mix 2X GoTaq® (Promega Corp.), 10 pmol of each primer and 2 μL (100 ng/μL) DNA, completing the volume with free nuclease water to obtain a final volume of 50 μL. PCR was performed for an initial denaturation of 5 min at 95 °C, followed by 30 cycles of 55 °C for 1 min, extension at 72 °C for 1 min, and denaturation at 95 °C for 1 min, followed by one step of final extension from 72 °C for 5 min. We followed the protocol described by Enright et al. [68].

The amplified products were sent for sequencing at Macrogen Incorporation (Seoul, South Korea). The sequencing chromatograms were analysed and trimmed, selecting only the sequenced nucleotides with Phred scores greater > 20 (accuracy > 99). Then, contigs of the nucleotide sequences were assembled using Geneious Prime version 2019.0. Subsequently, the sequences were aligned using Multiple Sequence Alignment - CLUSTALW with the software MEGA 7.0.21. Allele profiles, sequence types (STs) and clonal complexes were assigned using the MLST database (https://pubmlst.org/saureus/). Alleles and STs that had not been previously described were submitted to the database and were assigned as a new allele numbers and STs.

Statistical analyses

The presence/absence ratio of the virulence genes, resistance and multidrug efflux system (explanatory variables) with mastitis before and after treatment (response variable) were analysed by descriptive statistics and Multinomial logistic regression. Initially, a univariate logistic regression analysis was performed; the genes that had a significant effect (p < 0.05) were analysed by multivariate logistic regression, and only the genes with a significant effect (p < 0.05) were retained in the final model. The explanatory variables that did not present convergence problems in the logistic regression were evaluated by the Fisher-Freeman-Halton test. For the MIC data, descriptive statistics were used, based on the mean of three replicates. All analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC).

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

AMP:

Ampicillin

CC:

Clonal Complex

CFU:

Colony-forming unit

CIP:

Ciprofloxacin

CLSI:

Clinical and Laboratory Standards Institute

ENR:

Enrofloxacin

GEN:

Gentamicin

MFS:

Major facilitator superfamily

MH:

Müeller–Hinton

MIC:

Minimum inhibitory concentration

MLST:

Multilocus sequence typing

OD:

Optical density

OXA:

Oxacillin

PCR:

Polymerase Chain Reaction

PEN:

Penicillin

PFGE:

Pulsed-field gel electrophoresis

TET:

Tetracycline

VAN:

Vancomycin

References

  1. 1.

    Bergonier D, de Crémoux R, Rupp R, Lagriffoul G, Berthelot X. Mastitis of dairy small ruminants. Vet Res. 2003;34:689–716.

    PubMed  Article  Google Scholar 

  2. 2.

    Rainard P, Gitton C, Chaumeil T, Fassier T, Huau C, Riou M, et al. Host factors determine the evolution of infection with Staphylococcus aureus to gangrenous mastitis in goats. Vet Res. 2018:1–17. https://doi.org/10.1186/s13567-018-0564-4.

  3. 3.

    Elmas M, Tras B, Kaya S, Bas AL, Yazar E, Yarsan E. Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in angora goats. Can J Vet Res. 2001;65:64.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Attili AR, Preziuso S, Ngwa VN, Cantalamessa A, Moriconi M, Cuteri V. Clinical evaluation of the use of enrofloxacin against Staphylococcus aureus clinical mastitis in sheep. Small Rumin Res. 2016;136:72–7. https://doi.org/10.1016/j.smallrumres.2016.01.004.

    Article  Google Scholar 

  5. 5.

    Brauner A, Fridman O, Gefen O, Balaban NQ. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol. 2016;14:320–30.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Martins KB, Faccioli-martins PY, Flávio D, Riboli M, Pereira VC, Fernandes S, et al. Clonal profile, virulence and resistance of Staphylococcus aureus isolated from sheep milk. Braz J Microbiol. 2015;543:535–43.

    Article  Google Scholar 

  7. 7.

    Spanu V, Spanu C, Virdis S, Cossu F, Scarano C, Pietro E, et al. Virulence factors and genetic variability of Staphylococcus aureus strains isolated from raw sheep’s milk cheese. Int J Food Microbiol. 2012;153:53–7. https://doi.org/10.1016/j.ijfoodmicro.2011.10.015.

    PubMed  Article  Google Scholar 

  8. 8.

    Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Eleventh Edition. CLSI document M02-A11 ISBN 1–56238–782-0. 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087: Clinical and Laboratory Standards Institute; 2012.

  9. 9.

    MacGowan AP, Wise R. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J Antimicrob Chemother. 2001;48(suppl_1):17–28. https://doi.org/10.1093/jac/48.suppl_1.17.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Moroni P, Pisoni G, Vimercati C, Rinaldi M, Castiglioni B, Cremonesi P, et al. Characterization of Staphylococcus aureus isolated from chronically infected dairy goats. J Dairy Sci. 2010;88:3500–9.

    Article  Google Scholar 

  11. 11.

    Akkou M, Bentayeb L, Ferdji K, Medrouh B, Bachtarzi M-A, Ziane H, et al. Phenotypic characterization of staphylococci causing mastitis in goats and microarray-based genotyping of Staphylococcus aureus isolates. Small Rumin Res. 2018;169:29–33.

    Article  Google Scholar 

  12. 12.

    Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton-valentine Leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol. 2005;43:2384–90.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Bien J, Sokolova O, Bozko P. Characterization of virulence factors of Staphylococcus aureus: novel function of known virulence factors that are implicated in activation of airway epithelial Proinflammatory response. J Pathog. 2011;2011:1–13.

    Article  Google Scholar 

  14. 14.

    Jayaraman R. Bacterial persistence: some new insights into an old phenomenon. J Biosci. 2008;33:795–805.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Schmitz FJ, Krey A, Sadurski R, Verhoef J, Milatovic D, Fluit AC. Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates. J Antimicrob Chemother. 2001;47:239–40.

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Roberts MC. Update on acquired tetracycline resistance genes. FEMS Microbiol Lett. 2005;245:195–203.

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Kumar S, Mukherjee MM, Varela MF. Modulation of bacterial multidrug resistance efflux pumps of the major facilitator superfamily. Int J Bacteriol. 2013;2013:204141. https://doi.org/10.1155/2013/204141.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  18. 18.

    Oliveira DC, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis. 2002;2:180–9.

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Wang W, Lin X, Jiang T, Peng Z, Xu J, Yi L, et al. Prevalence and characterization of Staphylococcus aureus cultured from raw Milk taken from dairy cows with mastitis in Beijing, China. Front Microbiol. 2018;9:1123.

    PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Hata E. Bovine mastitis outbreak in Japan caused by methicillin-resistant Staphylococcus aureus New York/Japan clone. J Vet Diagn Investig. 2016;28:291–8.

    CAS  Article  Google Scholar 

  21. 21.

    Rola J, Czubkowska A, Korpysa-Dzirba W, Osek J. Occurrence of Staphylococcus aureus on Farms with Small Scale Production of Raw Milk Cheeses in Poland. Toxins (Basel). 2016;8:62.

    Article  CAS  Google Scholar 

  22. 22.

    Tarekgne EK, Skeie S, Rudi K, Porcellato D, Narvhus JA, Skjerdal T, et al. Enterotoxin gene profile and molecular characterization of Staphylococcus aureus isolates from bovine bulk milk and milk products of Tigray regio, Northern Ethiopian. J Food Prot. 2016;79:1387–95.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Basanisi MG, La Bella G, Nobili G, Franconieri I, La Salandra G. Genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolated from milk and dairy products in South Italy. Food Microbiol. 2017;62:141–6.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Altaf M, Ijaz M, Iqbal MK, Rehman A, Avais M, Ghaffar A, et al. Molecular characterization of methicillin resistant Staphylococcus aureus (MRSA) and associated risk factors with Ocurrence of goat mastitis. Pak Vet J. 2019;8318.

  25. 25.

    El-deeb W, Fayez M, Elmoslemany A, Kandeel M, Zidan K. Methicillin resistant Staphylococcus aureus among goat farms in Eastern province, Saudi Arabia: Prevalence and risk factors. Prev Vet Med. 2018;156:84–90. https://doi.org/10.1016/j.prevetmed.2018.05.005.

    PubMed  Article  Google Scholar 

  26. 26.

    Hauschild T, Vuković D, Dakić I, Ježek P, Djukić S, Dimitrijević V, et al. Aminoglycoside resistance in members of the Staphylococcus sciuri group. Microb Drug Resist. 2007;13:77–84. https://doi.org/10.1089/mdr.2007.713.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Costa SS, Viveiros M, Amaral L, Couto I. Multidrug efflux pumps in Staphylococcus aureus: an update. Open Microbiol J. 2013;7:59–71.

    PubMed  PubMed Central  Article  Google Scholar 

  28. 28.

    Luong TT, Newell SW, Lee CY. mgr, a Novel Global Regulator in Staphylococcus aureus. J Bacteriol. 2003;185:3703, LP–710. https://doi.org/10.1128/JB.185.13.3703-3710.2003.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  29. 29.

    Truong-Bolduc QC, Bolduc GR, Medeiros H, Vyas JM, Wang Y, Hooper DC. Role of the Tet38 efflux pump in Staphylococcus aureus internalization and survival in epithelial cells. Infect Immun. 2015;83:4362–72.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Truong-Bolduc QC, Strahilevitz J, Hooper DC. NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus. Antimicrob Agents Chemother. 2006;50:1104–7.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  31. 31.

    Crémieux A-C, Dumitrescu O, Lina G, Vallee C, Côté J-F, Muffat-Joly M, et al. Panton–valentine Leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One. 2009;4:e7204. https://doi.org/10.1371/journal.pone.0007204.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  32. 32.

    Mork T, Kvitle B, Mathisen T, Jorgensen HJ. Bacteriological and molecular investigations of Staphylococcus aureus in dairy goats. Vet Microbiol. 2010;141:134–41.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Ferens WA, Davis WC, Hamilton MJ, Park YH, Deobald CF, Fox L, et al. Activation of bovine lymphocyte subpopulations by staphylococcal enterotoxin C. Infect Immun. 1998;66:573–80. http://europepmc.org/articles/PMC107943.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Rossi BF, Bonsaglia ECR, Castilho IG, Dantas STA, Salina A, Langoni H, et al. Genotyping of long term persistent Staphylococcus aureus in bovine subclinical mastitis. Microb Pthogenes. 2019;132:45–50. https://doi.org/10.1016/j.micpath.2019.04.031.

    CAS  Article  Google Scholar 

  35. 35.

    Haveri M, Taponen S, Vuopio-Varkila J, Salmenlinna S, Pyörälä S. Bacterial genotype affects the manifestation and persistence of bovine Staphylococcus aureus Intramammary infection. J Clin Microbiol. 2005;43:959–61.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  36. 36.

    Concepción Porrero M, Hasman H, Vela AI, Fernández-Garayzábal JF, Domínguez L, Aarestrup FM. Clonal diversity of Staphylococcus aureus originating from the small ruminants goats and sheep. Vet Microbiol. 2012;156:157–61. https://doi.org/10.1016/j.vetmic.2011.10.015.

    PubMed  Article  Google Scholar 

  37. 37.

    de Almeida LM, de MZPRB a, de Mendonça CL, Mamizuka EM. Novel sequence types (STs) of Staphylococcus aureus isolates causing clinical and subclinical mastitis in flocks of sheep in the northeast of Brazil. J Dairy Res. 2011;78:373–8. https://doi.org/10.1017/S0022029911000379.

    PubMed  Article  CAS  Google Scholar 

  38. 38.

    Eriksson J, Espinosa-Gongora C, Stamphøj I, Larsen AR, Guardabassi L. Carriage frequency, diversity and methicillin resistance of Staphylococcus aureus in Danish small ruminants. Vet Microbiol. 2013;163:110–5 https://doi.org/10.1016/j.vetmic.2012.12.006.

    CAS  PubMed  Article  Google Scholar 

  39. 39.

    Guinane CM, Ben Zakour NL, Tormo-Mas MA, Weinert LA, Lowder BV, Cartwright RA, et al. Evolutionary genomics of Staphylococcus aureus reveals insights into the origin and molecular basis of ruminant host adaptation. Genome Biol Evol. 2010;2:454–66. https://doi.org/10.1093/gbe/evq031.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  40. 40.

    Smyth DS, Feil EJ, Meaney WJ, Hartigan PJ, Tollersrud T, Fitzgerald JR, et al. Molecular genetic typing reveals further insights into the diversity of animal-associated Staphylococcus aureus. J Med Microbiol. 2009;58:1343–53.

    PubMed  Article  Google Scholar 

  41. 41.

    Smith EM, Needs PF, Manley G, Green LE. Global distribution and diversity of ovine-associated Staphylococcus aureus. Infect Genet Evol. 2014;22:208–15. https://doi.org/10.1016/j.meegid.2013.09.008.

    PubMed  PubMed Central  Article  Google Scholar 

  42. 42.

    Zhou Z, Zhang M, Li H, Yang H, Li X, Song X, et al. Prevalence and molecular characterization of Staphylococcus aureus isolated from goats in Chongqing. China BMC Vet Res. 2017;13:352. https://doi.org/10.1186/s12917-017-1272-4.

    PubMed  Article  CAS  Google Scholar 

  43. 43.

    Hoekstra J, Rutten VPMG, van den Hout M, Spaninks MP, Benedictus L, Koop G. Differences between Staphylococcus aureus lineages isolated from ovine and caprine mastitis but not between isolates from clinical or subclinical mastitis. J Dairy Sci. 2019;102:5430–7. https://doi.org/10.3168/jds.2018-16196.

    CAS  PubMed  Article  Google Scholar 

  44. 44.

    Monecke S, Coombs G, Shore AC, Coleman DC, Akpaka P, Borg M, et al. A field guide to pandemic, Epidemic and Sporadic Clones of Methicillin-Resistant Staphylococcus aureus. PLoS One. 2011;6:e17936. https://doi.org/10.1371/journal.pone.0017936.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  45. 45.

    Li T, Lu H, Wang X, Gao Q, Dai Y, Shang J, et al. Molecular characteristics of Staphylococcus aureus causing bovine mastitis between 2014 and 2015. Front Cell Infect Microbiol. 2017;7:127. https://www.frontiersin.org/article/10.3389/fcimb.2017.00127.

    PubMed  PubMed Central  Google Scholar 

  46. 46.

    Rabello RF, Moreira BM, Lopes RMM, Teixeira LM, Riley LW, Castro ACD. Multilocus sequence typing of Staphylococcus aureus isolates recovered from cows with mastitis in Brazilian dairy herds. J Med Microbiol. 2007;56:1505–11.

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    El-Ashker M, Gwida M, Tomaso H, Monecke S, Ehricht R, El-Gohary F, et al. Staphylococci in cattle and buffaloes with mastitis in Dakahlia governorate. Egypt J Dairy Sci. 2015;98:7450–9. https://doi.org/10.3168/jds.2015-9432.

    CAS  PubMed  Article  Google Scholar 

  48. 48.

    Bergonier D, Sobral D, Feßler AT, Jacquet E, Gilbert FB, Schwarz S, et al. Staphylococcus aureus from 152 cases of bovine, ovine and caprine mastitis investigated by multiple-locus variable number of tandem repeat analysis (MLVA). Vet Res. 2014;45:97. https://doi.org/10.1186/s13567-014-0097-4.

    PubMed  PubMed Central  Article  Google Scholar 

  49. 49.

    Aires-de-Sousa M, Parente CESR, Vieira-da-Motta O, Bonna ICF, Silva DA, De Lencastre H. Characterization of Staphylococcus aureus isolates from buffalo, bovine, ovine, and caprine milk samples collected in Rio de Janeiro state, Brazil . Appl Environ Microbiol. 2007;73:3845–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Ji Y. Methicillin-resistant Staphylococcus aureus (MRSA) protocols. Second Edi. Totowa, NJ: Humana Press; 2014.

    Google Scholar 

  51. 51.

    Bens CCPM, Voss A, Klaassen CHW. Presence of a novel DNA methylation enzyme in methicillin-resistant Staphylococcus aureus isolates associated with pig farming leads to Uninterpretable results in standard pulsed-field gel electrophoresis analysis. J Clin Microbiol. 2006;44:1875–6.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  52. 52.

    Dittmann KK, Chaul LT, Lee SHI, Corassin CH, de Oliveira CAF, De Martinis ECP, et al. Staphylococcus aureus in some Brazilian dairy industries: Changes of contamination and diversity. Front Microbiol. 2017;8:2049.

    PubMed  PubMed Central  Article  Google Scholar 

  53. 53.

    Cohen NR, Lobritz MA, Collins JJ. Microbial persistence and the road to drug resistance. Cell Host Microbe. 2013;13:632–42. https://doi.org/10.1016/j.chom.2013.05.009.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  54. 54.

    Pu Y, Zhao Z, Li Y, Zou J, Ma Q, Zhao Y, et al. Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells. Mol Cell. 2016;62:284–94. https://doi.org/10.1016/j.molcel.2016.03.035.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  55. 55.

    Cirz RT, Jones MB, Gingles NA, Minogue TD, Jarrahi B, Peterson SN, et al. Complete and SOS-Mediated Response of Staphylococcus aureus to the Antibiotic Ciprofloxacin. J Bacteriol. 2007;189:531, LP–539. https://doi.org/10.1128/JB.01464-06.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  56. 56.

    Schelli K, Zhong F, Zhu J. Comparative metabolomics revealing Staphylococcus aureus metabolic response to different antibiotics. Microb Biotechnol. 2017;10:1764–74. https://doi.org/10.1111/1751-7915.12839.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  57. 57.

    Dermott WMC. Microbial persistence. Yale J Biol Med. 1958;30:257–91.

    Google Scholar 

  58. 58.

    Lima MC, Souza MCC, Espeschit IF, Maciel PACC, Sousa JE, Moraes GF, et al. Mastitis in dairy goats from the state of Minas Gerais, Brazil: profiles of farms, risk factors and characterization of bacteria. Pesqui Vet Bras. 2018;38:1742–51.

    Article  Google Scholar 

  59. 59.

    Choi SM, Kim SH, Kim HJ, Lee DG, Choi JH, Yoo JH, et al. Multiplex PCR for the detection of genes encoding aminoglycoside modifying enzymes and methicillin resistance among Staphylococcus Species. J Korean Med Sci. 2003;18:631–6.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  60. 60.

    Ruegg PL, Oliveira L, Jin W, Okwumabua O. Phenotypic antimicrobial susceptibility and occurrence of selected resistance genes in gram-positive mastitis pathogens isolated from Wisconsin dairy cows. J Dairy Sci. 2015;98:1–14. https://doi.org/10.3168/jds.2014-9137.

    Article  CAS  Google Scholar 

  61. 61.

    Martineau F, Picard FJ, Lansac N, Ménard C, Roy PH, Ouellette M, et al. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 2000;44:231–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  62. 62.

    Floyd JL, Smith KP, Kumar SH, Floyd JT, Varela MF. LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. Antimicrob Agents Chemother. 2010;54:5406–12.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  63. 63.

    Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, et al. Relationships between Staphylococcus aureus Genetic Background, Virulence Factors, agr Groups (Alleles), and Human Disease. Infect Immun. 2002;70:631 LP–641.

    Article  CAS  Google Scholar 

  64. 64.

    Tristan A, Ying L, Bes M, Etienne J, Vandenesch F, Lina G. Use of Multiplex PCR To Identify Staphylococcus aureus Adhesins Involved in Human Hematogenous Infections. J Clin Microbiol. 2003;41:4465 LP–4467.

    Article  CAS  Google Scholar 

  65. 65.

    Bania J, Dabrowska A, Korzekwa K, Zarczynska A, Bystron J, Chrzanowska J, et al. The profiles of enterotoxin genes in Staphylococcus aureus from nasal carriers. Lett Appl Microbiol. 2006;42:315–20.

    CAS  PubMed  Article  Google Scholar 

  66. 66.

    Spanamberg A, Wunder EAJ, Brayer Pereira DI, Argenta J, Cavallini Sanches EM, Valente P, et al. Diversity of yeasts from bovine mastitis in southern Brazil. Rev Iberoam Micol. 2008;25:154–6.

    PubMed  Article  Google Scholar 

  67. 67.

    Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  68. 68.

    Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38:1008–15.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank professor Ricardo Seiti Yamatogi from Universidade Federal de Viçosa for his collaboration in interpreting the results of PFGE.

Funding

Financial support was received from CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brasília, Brazil) in the form of research funding (inputs and equipment) and scholarships, FAPEMIG (Fundação de Amparo à Pesquisa de Minas Gerais, Belo Horizonte, Brazil)) in the form of research funding (inputs and equipment) and scholarships, and CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brasília, Brazil, Finance Code 001) in the form of scholarships. Maria Aparecida Scatamburlo Moreira and Mateus Matiuzzi da Costa are supported by CNPq.

Author information

Affiliations

Authors

Contributions

MCL performed, analyzed and interpreted all data and was a contributor in writing the manuscript. MB interpreted all data and was a major contributor in writing the manuscript. TMS performed and analyzed the PFGE data. RCP analyzed and interpreted MLST data. LKC and SHSG performed and analyzed PCRs. SLC and MMC analyzed and interpreted all data. MASM was the adviser, contributing in analyze and interpretation besides of defining the goals of the study. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Maria Aparecida Scatamburlo Moreira.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Committee of Ethics in the Use of Animals of the Universidade Federal de Viçosa, CEUA/UFV, with study number 42/2014.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lima, M.C., de Barros, M., Scatamburlo, T.M. et al. Profiles of Staphyloccocus aureus isolated from goat persistent mastitis before and after treatment with enrofloxacin. BMC Microbiol 20, 127 (2020). https://doi.org/10.1186/s12866-020-01793-9

Download citation

Keywords

  • Caprine mastitis
  • Small ruminants
  • Persistence